Sidi Chen, PhD: The Light at the End of the Tunnel
Years Funded: 2020-2022
Initial Development of a Novel CRISPRa-Based Immune Gene Therapy for PDAC
Sidi Chen, PhD, assistant professor in the Yale University School of Medicine Department of Genetics, Systems Biology Institute and Cancer Center (West Haven, CT) is taking on the challenges of pancreatic cancer with an innovative, versatile and highly scalable strategy he calls MAEGI — Multiplexed Activation of Endogenous Genes as an Immunotherapy.